Utility Study in Diffuse Large B-Cell Lymphoma (DLBCL)
Completed
- Conditions
- Diffuse Large B-Cell Lymphoma
- Registration Number
- NCT02708732
- Lead Sponsor
- Hoffmann-La Roche
- Brief Summary
This study is a prospective, cross-sectional survey to be administered to real patients in remission from DLBCL using a 15-minute postal or online survey. The project is designed to describe the impact of DLBCL remission on health utility and quality of life. Data collection will occur over a 4-month period.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 91
Inclusion Criteria
- Adults greater than or equal to (>/=) 18 years of age
- Diagnosis of DLBCL and currently in first remission
- Prior drug treatment for DLBCL
Exclusion Criteria
- Receiving active treatment for DLBCL
- Relapsed following any treatment for DLBCL
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Health-Related Quality of Life According to European Quality of Life 5-Dimension 5-Level (EQ-5D-5L) Score Up to 4 months of data collection
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms influence health utility in DLBCL remission patients as studied in NCT02708732?
How does DLBCL remission impact quality of life compared to standard-of-care treatment outcomes?
Are specific biomarkers associated with improved health utility in NCT02708732 DLBCL patients?
What adverse events are reported in DLBCL remission studies using observational methods like NCT02708732?
How do Roche's DLBCL therapeutic strategies compare to other observational studies in patient quality of life?
Trial Locations
- Locations (1)
PH Associates - an OPen Health Company
🇬🇧Marlow, United Kingdom
PH Associates - an OPen Health Company🇬🇧Marlow, United Kingdom